| ★ | WIML Part 2: High throughput compound screening | | 735 | Estados Unidos | |
| 1 | WIML: How chemicals are developed in the lab | | 3.5K | Estados Unidos | 93 |
| 12 | WIML Part 3: Visualization using microscopy | | 970 | Estados Unidos | 88 |
| 14 | WIML Part 1: How T-cell engagers are tested in the lab | | 929 | Estados Unidos | 87 |
| 13 | WIML: What is Liquid Chromatography-Mass Spectrometry? | | 650 | Estados Unidos | 88 |
| 8 | WIML: How Joyann’s team creates molecules | | 636 | Estados Unidos | 89 |
| 4 | WIML: Isolating a target molecule from impurities | | 634 | Estados Unidos | 90 |
| 20 | New Drug Breakthrough | Medical Centric Podcast @medicalcentric | 581 | Portugal | 87 |
| 7 | WIML: How Nuclear Magnetic Resonance can prove a compound’s identity | | 540 | Estados Unidos | 89 |
| 2 | WIML: Creating cell models to test potential drugs | | 474 | Estados Unidos | 92 |
| 10 | WIML: Purifying mixtures with a rotovap | | 440 | Estados Unidos | 89 |
| 3 | WIML: Using imaging to see how potential drugs function | | 409 | Estados Unidos | 92 |
| 19 | Testing of Hypothesis 2 | TLC Ramanujan College @tlcramanujancollege | 199 | India | 87 |
| 11 | Day Two at the Global Genes Rare Drug Development Symposium 2025 | | 46 | — | 88 |
| 16 | CEPYME 500 2025. Resumen de l acto de presentación de la IX edición de CEPYME500 | | 39 | España | 87 |
| 18 | BIOCMPUTING | DEEP ECOLOGY AND GREEN POLITICAL IDEOLOGY @greenpartyofmalaysia | 38 | — | 87 |
| 17 | Biotechnology | | 15 | — | 87 |
| 15 | UPR PGx Lab: Tomorrow’s Medicine in Today’s Practice | RCMI Program UPR Medical Sciences Campus @ciartech | 12 | — | 87 |
| 5 | Revolutionizing Medicine Unveiling New Targets in Drug Discovery 💊 | Microlearning Daily @microlearningdaily | 10 | Singapur | 90 |
| 9 | Inside the Lab Secrets of Formulation Equipment and Decisions 🧪 | Microlearning Daily @microlearningdaily | 5 | Singapur | 89 |
| 6 | The process of drug discovery and development | Blue Current @bluecurrent7 | 0 | India | 89 |